Tag: Vaccines
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone
CDC Panel Gives Support to New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
ChatGPT Accurately Handles Questions About Vaccine Hesitancy
Findings seen for 50 most common questions about false information, myths, and false and true contraindications
Flu Vaccine Cut Risk for Influenza-Linked Hospitalizations in 2023
Interim data show vaccine effectiveness of 51.9 percent in five South American countries during their flu season
FDA Approves New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
Severity Reduced With Mpox Reinfection, Postvaccination Infection
Shorter disease course with less mucosal disease seen on reinfection versus initial infection
Providers Have Inadequate Awareness of PCV20 Vaccination Recommendations
Two-thirds of health care providers agree with expanding recommendations for new PCV20
FDA Approval of New COVID-19 Boosters Could Come by Friday
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
Moderna Says Updated COVID-19 Vaccine Shields Against Highly Mutated New Variant
Scientists found the variant appears to be less concerning than initially thought, with data showing it is 60 percent less infectious than XBB.1.5 variants
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines
